OBJECTIVE: Dimethylfumarate (DMF) is used in the treatment of psoriasis. Macrophage migration inhibitory factor (MIF) is elevated in patients with severe psoriasis. We studied the effect of DMF on the MIF-induced activation of the mitogen- and stress-activated kinase 1 (MSK1) and p90 kDa ribosomal S6 kinase (RSK1) signaling pathways which regulate the proliferation of human keratinocytes via transcription factors. METHODS: The effects of DMF on the MIF-induced activation of MSK1, RSK1, cAMP-responsive element-binding protein (CREB), Cox-2 and c-Jun, JunB and p53 were studied by Western blotting using phospho-specific antibodies. RESULTS: DMF inhibited the MIF-induced phosphorylation of MSK1, RSK1, CREB and JunB, and reduced Cox-2 expression and the proliferation of cultured human keratinocytes. The expression of p-p53 (S15) was induced simultaneously with the inhibition of Cox-2. Addition of DMF before MIF induced nuclear expression of p-c-Jun (S63) and c-Jun. Transfection with small interfering MSK1 and RSK1 RNA before MIF incubation stimulated p-p53 (S15) and nuclear p-c-Jun (S63) similarly to DMF. CONCLUSION: Our results indicate that the specific inhibitory effects of DMF on RSK1 and MSK1 activation together with the induction of p-c-Jun (S63) and p-p53 (S15) lead to the inhibition of keratinocyte proliferation, partly explaining the anti-psoriatic effect of DMF.
OBJECTIVE:Dimethylfumarate (DMF) is used in the treatment of psoriasis. Macrophage migration inhibitory factor (MIF) is elevated in patients with severe psoriasis. We studied the effect of DMF on the MIF-induced activation of the mitogen- and stress-activated kinase 1 (MSK1) and p90 kDa ribosomal S6 kinase (RSK1) signaling pathways which regulate the proliferation of human keratinocytes via transcription factors. METHODS: The effects of DMF on the MIF-induced activation of MSK1, RSK1, cAMP-responsive element-binding protein (CREB), Cox-2 and c-Jun, JunB and p53 were studied by Western blotting using phospho-specific antibodies. RESULTS:DMF inhibited the MIF-induced phosphorylation of MSK1, RSK1, CREB and JunB, and reduced Cox-2 expression and the proliferation of cultured human keratinocytes. The expression of p-p53 (S15) was induced simultaneously with the inhibition of Cox-2. Addition of DMF before MIF induced nuclear expression of p-c-Jun (S63) and c-Jun. Transfection with small interfering MSK1 and RSK1 RNA before MIF incubation stimulated p-p53 (S15) and nuclear p-c-Jun (S63) similarly to DMF. CONCLUSION: Our results indicate that the specific inhibitory effects of DMF on RSK1 and MSK1 activation together with the induction of p-c-Jun (S63) and p-p53 (S15) lead to the inhibition of keratinocyte proliferation, partly explaining the anti-psoriatic effect of DMF.
Authors: Kristian Otkjaer; Knud Kragballe; Claus Johansen; Anne T Funding; Helle Just; Uffe B Jensen; Lotte G Sørensen; Peder L Nørby; Jes T Clausen; Lars Iversen Journal: J Invest Dermatol Date: 2007-01-25 Impact factor: 8.551
Authors: T Shimizu; J Nishihira; Y Mizue; H Nakamura; R Abe; H Watanabe; A Ohkawara; H Shimizu Journal: J Invest Dermatol Date: 2001-06 Impact factor: 8.551
Authors: Xijing Zhang; Liangwei Chen; Yazhou Wang; Yinxiu Ding; Zhengwu Peng; Li Duan; Gong Ju; Yi Ren; Xi Wang Journal: Int J Biol Sci Date: 2013-11-28 Impact factor: 6.580
Authors: Victoria A McGuire; Tamara Ruiz-Zorrilla Diez; Christoph H Emmerich; Sam Strickson; Maria Stella Ritorto; Ruhcha V Sutavani; Anne Weiβ; Kirsty F Houslay; Axel Knebel; Paul J Meakin; Iain R Phair; Michael L J Ashford; Matthias Trost; J Simon C Arthur Journal: Sci Rep Date: 2016-08-08 Impact factor: 4.379
Authors: Mads K Rasmussen; Jakob Nielsen; Rasmus B Kjellerup; Stine M Andersen; Anne H Rittig; Claus Johansen; Lars Iversen; Borbala Gesser Journal: J Inflamm Res Date: 2017-12-15
Authors: Siegfried Bezdek; Lin Leng; Hauke Busch; Sadegh Mousavi; Dirk Rades; Markus Dahlke; Detlef Zillikens; Richard Bucala; Christian D Sadik Journal: Front Immunol Date: 2018-10-02 Impact factor: 7.561